Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas A Russo

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|February 17, 2022
Clinical Isolates of <i>Acinetobacter</i> spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement SystemMichal Magda, Serena Bettoni, Maisem Laabei, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 5, 2019
Antibody Dependent Enhancement of <i>Acinetobacter baumannii</i> Infection in a Mouse Pneumonia ModelShun Xin Wang-Lin, Ruth Olson, Janet M Beanan, et al.
Infection and Immunity|September 27, 2017
The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization StrategiesShun Xin Wang-Lin, Ruth Olson, Janet M Beanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
High frequency of hotspot mutations in core genes of Escherichia coli due to short-term positive selectionSujay Chattopadhyay, Scott J Weissman, Vladimir N Minin, et al.
Clinical and Diagnostic Laboratory Immunology|July 10, 2004
Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumoniaPatricia A Manderscheid, Ryan P Bodkin, Bruce A Davidson, et al.
Msphere|June 16, 2016
The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumanniiThomas A Russo, Akshay Manohar, Janet M Beanan, et al.
Microbial Pathogenesis|July 16, 2013
OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsisJames R Johnson, Thomas A Russo, Sarah M Drawz, et al.
Infection and Immunity|November 26, 2003
The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidateThomas A Russo, Catherine D McFadden, Ulrike B Carlino-MacDonald, et al.
Critical Care Medicine|April 20, 2004
Gastric acid and particulate aspiration injury inhibits pulmonary bacterial clearanceAlexandre T Rotta, Kevin T Shiley, Bruce A Davidson, et al.
Infection and Immunity|March 26, 2014
Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniaeThomas A Russo, Ruth Olson, Ulrike Macdonald, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|February 17, 2022
Clinical Isolates of <i>Acinetobacter</i> spp. Are Highly Serum Resistant Despite Efficient Recognition by the Complement SystemMichal Magda, Serena Bettoni, Maisem Laabei, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 5, 2019
Antibody Dependent Enhancement of <i>Acinetobacter baumannii</i> Infection in a Mouse Pneumonia ModelShun Xin Wang-Lin, Ruth Olson, Janet M Beanan, et al.
Infection and Immunity|September 27, 2017
The Capsular Polysaccharide of Acinetobacter baumannii Is an Obstacle for Therapeutic Passive Immunization StrategiesShun Xin Wang-Lin, Ruth Olson, Janet M Beanan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
High frequency of hotspot mutations in core genes of Escherichia coli due to short-term positive selectionSujay Chattopadhyay, Scott J Weissman, Vladimir N Minin, et al.
Clinical and Diagnostic Laboratory Immunology|July 10, 2004
Bacterial clearance and cytokine profiles in a murine model of postsurgical nosocomial pneumoniaPatricia A Manderscheid, Ryan P Bodkin, Bruce A Davidson, et al.
Msphere|June 16, 2016
The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumanniiThomas A Russo, Akshay Manohar, Janet M Beanan, et al.
Microbial Pathogenesis|July 16, 2013
OxyR contributes to the virulence of a Clonal Group A Escherichia coli strain (O17:K+:H18) in animal models of urinary tract infection, subcutaneous infection, and systemic sepsisJames R Johnson, Thomas A Russo, Sarah M Drawz, et al.
Infection and Immunity|November 26, 2003
The Siderophore receptor IroN of extraintestinal pathogenic Escherichia coli is a potential vaccine candidateThomas A Russo, Catherine D McFadden, Ulrike B Carlino-MacDonald, et al.
Critical Care Medicine|April 20, 2004
Gastric acid and particulate aspiration injury inhibits pulmonary bacterial clearanceAlexandre T Rotta, Kevin T Shiley, Bruce A Davidson, et al.
Infection and Immunity|March 26, 2014
Aerobactin mediates virulence and accounts for increased siderophore production under iron-limiting conditions by hypervirulent (hypermucoviscous) Klebsiella pneumoniaeThomas A Russo, Ruth Olson, Ulrike Macdonald, et al.
Pageof 10